161 related articles for article (PubMed ID: 3965675)
21. [Monitoring and appraisal of the effects of blood transfusion and iron chelation in thalassemia major].
Girot R; Triadou P; Bories D; Jeannel F; Thevenin M; Rymer JC
Nouv Rev Fr Hematol (1978); 1982; 24(5):281-7. PubMed ID: 7167380
[TBL] [Abstract][Full Text] [Related]
22. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
[TBL] [Abstract][Full Text] [Related]
23. Growth and management of short stature in thalassaemia major.
Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
[TBL] [Abstract][Full Text] [Related]
24. Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province.
Abdelrazik N; Ghanem H
Hematology; 2007 Oct; 12(5):449-56. PubMed ID: 17852439
[TBL] [Abstract][Full Text] [Related]
25. [Longitudinal growth of patients with homozygote beta-thalassemia during continuous subcutaneous infusion of deferoxamine].
Krüger N; Stubbe P; Tillmann W; Schröter W
Dtsch Med Wochenschr; 1986 Jan; 111(5):176-81. PubMed ID: 3943469
[TBL] [Abstract][Full Text] [Related]
26. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
27. [Growth and endocrine function in major thalassemia].
Pérignon F; Brauner R; Souberbielle JC; de Montalembert M; Girot R
Arch Fr Pediatr; 1993 Oct; 50(8):657-63. PubMed ID: 8002739
[TBL] [Abstract][Full Text] [Related]
28. The clinical management of homozygous beta-thalassemia.
Cividalli G
Haematologica; 1979 Feb; 64(1):1-12. PubMed ID: 109360
[No Abstract] [Full Text] [Related]
29. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation.
Aldouri MA; Wonke B; Hoffbrand AV; Flynn DM; Ward SE; Agnew JE; Hilson AJ
Acta Haematol; 1990; 84(3):113-7. PubMed ID: 2123060
[TBL] [Abstract][Full Text] [Related]
30. Final height and endocrine function in thalassaemia intermedia.
De Sanctis V; Tangerini A; Testa MR; Lauriola AL; Gamberini MR; Cavallini AR; Rigolin F
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():965-71. PubMed ID: 10091174
[TBL] [Abstract][Full Text] [Related]
31. The management of the improved prognosis in thalassemia major.
Modell B
Birth Defects Orig Artic Ser; 1982; 18(7):329-37. PubMed ID: 6819016
[No Abstract] [Full Text] [Related]
32. Growth retardation, skeletal maturation and thyroid function in children with homozygous beta-thalassaemia.
Madeddu G; Dore A; Marongiu A; Langer-Costanzi M
Clin Endocrinol (Oxf); 1978 May; 8(5):359-65. PubMed ID: 206391
[TBL] [Abstract][Full Text] [Related]
33. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
Giardina PJ; Grady RW
Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
[TBL] [Abstract][Full Text] [Related]
34. COMPARISON OF SIXTY-SIX PATIENTS WITH THALASSEMIA MAJOR AND THIRTEEN PATIENTS WITH THALASSEMIA INTERMEDIA: INCLUDING EVALUATIONS OF GROWTH, DEVELOPMENT, MATURATION AND PROGNOSIS.
ERLANDSON ME; BRILLIANT R; SMITH CH
Ann N Y Acad Sci; 1964 Oct; 119():727-35. PubMed ID: 14219452
[No Abstract] [Full Text] [Related]
35. Short stature and truncal shortening in transfusion dependent thalassemia patients: results from a thalassemia center in Malaysia.
Hamidah A; Rahmah R; Azmi T; Aziz J; Jamal R
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):625-30. PubMed ID: 11944728
[TBL] [Abstract][Full Text] [Related]
36. Modern management of thalassemia.
Festa RS
Pediatr Ann; 1985 Sep; 14(9):597-600, 602-3, 606. PubMed ID: 3903631
[No Abstract] [Full Text] [Related]
37. Problems related to treatment of beta-thalassaemia major.
Economidou J
Paediatrician; 1982; 11(3-4):157-77. PubMed ID: 7043374
[TBL] [Abstract][Full Text] [Related]
38. Some clinical features of Cooley's anemia patients as related to transfusion schedules.
Wolman IJ; Ortolani M
Ann N Y Acad Sci; 1969 Nov; 165(1):407-14. PubMed ID: 5260163
[No Abstract] [Full Text] [Related]
39. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
Silvestroni E; Bianco I; Graziani B; Lerone M; Valente M; Congedo P; Ponzini D; Costantini S
Acta Haematol; 1982; 68(2):115-23. PubMed ID: 6812366
[TBL] [Abstract][Full Text] [Related]
40. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
